Evidence check: Skincare DNA in the context of menopause

Evidence for skincare DNA tests in menopause is weak. While some genetic variants (e.g., COL1A1 rs1800012 for collagen, NQO1 rs1800566 for detox) have small associations with skin aging, their effect is minor and not menopause-specific. Most commercial tests rely on low-effect SNPs and overstate actionable advice (e.g., 'take this supplement'). Menopause skin changes are driven primarily by estrogen decline, which DNA cannot predict. A responsible approach includes clinical skin assessment, lifestyle factors, and possibly hormone therapy. DNA alone does not guide skincare. Be cautious of marketing claims.